dc.contributor.author | McGinnis, Timothy | |
dc.contributor.author | Bantis, Leonidas E. | |
dc.contributor.author | Madan, Rashna | |
dc.contributor.author | Dandawate, Prasad | |
dc.contributor.author | Kumer, Sean | |
dc.contributor.author | Schmitt, Timothy | |
dc.contributor.author | Paluri, Ravi Kumar | |
dc.contributor.author | Kasi, Anup | |
dc.date.accessioned | 2021-06-23T16:23:20Z | |
dc.date.available | 2021-06-23T16:23:20Z | |
dc.date.issued | 2020-09-25 | |
dc.identifier.citation | McGinnis, T.; Bantis, L.E.; Madan, R.; Dandawate, P.; Kumer, S.; Schmitt, T.; Paluri, R.K.; Kasi, A. Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma. J. Clin. Med. 2020, 9, 3102. https://doi.org/10.3390/jcm9103102 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/31694 | |
dc.description | A grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml. | en_US |
dc.description.abstract | Pancreatic intraepithelial neoplasms (PanINs) and intraductal papillary mucinous neoplasms (IPMNs) are common pancreatic adenocarcinoma precursor lesions. However, data regarding their respective associations with survival rate and prognosis are lacking. We retrospectively evaluated 72 pancreatic adenocarcinoma tumor resection patients at the University of Kansas Hospital between August 2009 and March 2019. Patients were divided into one of two groups, PanIN or IPMN, based on the results of the surgical pathology report. We compared baseline characteristics, overall survival (OS), and progression free survival (PFS) between the two groups, as well as OS and PFS based on local or distant tumor recurrence for both groups combined. 52 patients had PanINs and 20 patients had IPMNs. Patients who had an IPMN precursor lesion had better median PFS and OS when compared to patients with PanIN precursor lesions. However, the location of tumor recurrence (local or distant) did not show a statistically significant difference in OS. | en_US |
dc.publisher | MDPI | en_US |
dc.rights | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
dc.subject | Pancreatic cancer | en_US |
dc.subject | PanIN | en_US |
dc.subject | IPMN | en_US |
dc.subject | Pancreatic adenocarcinoma | en_US |
dc.subject | Precursor lesion | en_US |
dc.title | Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma | en_US |
dc.type | Article | en_US |
kusw.kuauthor | McGinnis, Timothy | |
kusw.kuauthor | Bantis, Leonidas E. | |
kusw.kuauthor | Madan, Rashna | |
kusw.kuauthor | Dandawate, Prasad | |
kusw.kuauthor | Kumer, Sean | |
kusw.kuauthor | Schmitt, Timothy | |
kusw.kuauthor | Kasi, Anup | |
kusw.kudepartment | KU Medical Center | en_US |
dc.identifier.doi | 10.3390/jcm9103102 | en_US |
kusw.oaversion | Scholarly/refereed, publisher version | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.rights.accessrights | openAccess | en_US |